Literature DB >> 31628816

Hyperglycemia-induced ubiquitination and degradation of β-catenin with the loss of platelet endothelial cell adhesion molecule-1 in retinal endothelial cells.

Randa S Eshaq1, Norman R Harris1.   

Abstract

OBJECTIVE: Increased retinal vascular permeability is one of the earliest manifestations of diabetic retinopathy. The aim of this study was to investigate the role of hyperglycemia-induced platelet endothelial cell adhesion molecule-1 loss on retinal vascular permeability via the β-catenin pathway.
METHODS: Type I diabetes was induced in male Wistar rats using streptozotocin injections, with age-matched non-diabetic rats as controls. Rat retinal microvascular endothelial cells were grown under normal or high glucose conditions for 6 days. Small interfering Ribonucleic Acid was used to knock down platelet endothelial cell adhesion molecule-1 in rat retinal microvascular endothelial cells for loss-of-function studies. Retinas and rat retinal microvascular endothelial cells were subjected to Western blot, immunofluorescence labeling, and co-immunoprecipitation analyses to assess protein levels and interactions. A biotinylated gelatin and fluorescein isothiocyanate-avidin assay was used for retinal endothelial cell permeability studies.
RESULTS: β-catenin, β-catenin/platelet endothelial cell adhesion molecule-1 interaction, active Src homology 2 domain-containing protein tyrosine phosphatase were significantly decreased, while β-catenin ubiquitination levels and endothelial permeability were significantly increased, in hyperglycemic retinal endothelial cells. Similar results were observed with platelet endothelial cell adhesion molecule-1 partial knockdown, where β-catenin and active Src homology 2 domain-containing protein tyrosine phosphatase levels were decreased, while phospho-β-catenin and retinal endothelial cell permeability were increased.
CONCLUSION: Platelet endothelial cell adhesion molecule-1 loss may contribute to increased retinal endothelial cell permeability by attenuating β-catenin levels under hyperglycemic conditions.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  PECAM-1; blood-retinal barrier; diabetic retinopathy; permeability; β-catenin

Mesh:

Substances:

Year:  2019        PMID: 31628816      PMCID: PMC7032995          DOI: 10.1111/micc.12596

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  43 in total

Review 1.  The various roles of ubiquitin in Wnt pathway regulation.

Authors:  Daniele V F Tauriello; Madelon M Maurice
Journal:  Cell Cycle       Date:  2010-09-25       Impact factor: 4.534

Review 2.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

3.  Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.

Authors:  Donnasue Graesser; Anna Solowiej; Monika Bruckner; Emily Osterweil; Amy Juedes; Sandra Davis; Nancy H Ruddle; Britta Engelhardt; Joseph A Madri
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.

Authors:  Sharon Amit; Ada Hatzubai; Yaara Birman; Jens S Andersen; Etti Ben-Shushan; Matthias Mann; Yinon Ben-Neriah; Irit Alkalay
Journal:  Genes Dev       Date:  2002-05-01       Impact factor: 11.361

5.  beta-catenin is a target for the ubiquitin-proteasome pathway.

Authors:  H Aberle; A Bauer; J Stappert; A Kispert; R Kemler
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

6.  PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis.

Authors:  Cunji Gao; Weiyong Sun; Melpo Christofidou-Solomidou; Motoshi Sawada; Debra K Newman; Carmen Bergom; Steven M Albelda; Shigemi Matsuyama; Peter J Newman
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

7.  Partial characterization of the human retinal endothelial cell tight and adherens junction complexes.

Authors:  P K Russ; M K Davidson; L H Hoffman; F R Haselton
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-11       Impact factor: 4.799

8.  Vascular-endothelial-cadherin modulates endothelial monolayer permeability.

Authors:  P L Hordijk; E Anthony; F P Mul; R Rientsma; L C Oomen; D Roos
Journal:  J Cell Sci       Date:  1999-06       Impact factor: 5.285

Review 9.  Endothelial cell-cell junctions: happy together.

Authors:  Elisabetta Dejana
Journal:  Nat Rev Mol Cell Biol       Date:  2004-04       Impact factor: 94.444

10.  Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule.

Authors:  S M Albelda; W A Muller; C A Buck; P J Newman
Journal:  J Cell Biol       Date:  1991-09       Impact factor: 10.539

View more
  3 in total

1.  Hyperglycemia-induced effects on glycocalyx components in the retina.

Authors:  Gaganpreet Kaur; Janet Rogers; Nabil A Rashdan; Diana Cruz-Topete; Christopher B Pattillo; Steven D Hartson; Norman R Harris
Journal:  Exp Eye Res       Date:  2021-11-18       Impact factor: 3.770

2.  LECT2 Ameliorates Blood-Retinal Barrier Impairment Secondary to Diabetes Via Activation of the Tie2/Akt/mTOR Signaling Pathway.

Authors:  Yuan-Jun Qin; Ke Xiao; Zheng Zhong; Yin Zhao; Tian Yu; Xu-Fang Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

3.  A Mechanistic Exploratory Study on the Therapeutic Efficacy of Astragaloside IV Against Diabetic Retinopathy Revealed by Network Pharmacology.

Authors:  Zhi-Hao Zhao; Min Xu; Cong Fu; Ying Huang; Ting-Hua Wang; Zhong-Fu Zuo; Xue-Zheng Liu
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.